Navigation Links
Cumberland Pharmaceuticals Reports Third Quarter 2010 Financial Results
Date:11/11/2010

, 2010. Total assets as of September 30, 2010, were $89.9 million compared with $96.7 million at June 30, 2010.  

"We continue to grow our established brands, Acetadote and Kristalose, and to progress our efforts to gain wide formulary acceptance for Caldolor," said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. "As we prepare to drive pull-through sales for Caldolor in 2011, we are assembling a growing armamentarium of training and marketing tools to shift efforts within hospitals and surgery centers to reach a much larger target audience."

Cumberland is raising its full year 2010 revenue guidance from its previous expectations of $42 - $43 million. The Company now expects to see net revenue of $43 - $45 million for the twelve-month period ended December 31, 2010. This guidance represents the Company's best estimate of future results, which may be affected by factors described below in "Forward-Looking Statements."

RECENT DEVELOPMENTSSubmission of Supplemental New Drug Application for New Formulation of Acetadote

In October 2010, Cumberland submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for approval of a new formulation of Acetadote, which is designed to replace the currently marketed product and is the result of the Company's commitment to further developing its products. Cumberland is supporting the FDA's review of the application and is preparing to make this new formulation available to patients.

The Company expects to receive a response from the FDA regarding the new formulation by early January 2011 and, if approved, would commence with the new product launch immediately. Cumberland has filed a patent application with the U.S. Patent and Trademark Office to protect this proprietary new formulation.

Supplemental New Drug Application for Acetadote in Treating Acute Liver Failure

In March 2010, Cumberland submitted it
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 11, 2010
2. Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia
3. Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application
4. Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
5. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
6. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
7. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
8. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
9. Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
10. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
11. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... and HERZLIYA PITUACH, Israel, Nov. 25, 2014 ... or "the Company"), a clinical stage biopharmaceutical company ... targeted therapeutics for the treatment of inflammatory diseases ... previously announced underwritten public offering of 3,450,000 units, ... the Company,s common stock, par value $0.0001 per ...
(Date:11/24/2014)... -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today that ... update at the Piper Jaffray 26 th Annual Healthcare ... Time (5:30 a.m. Pacific Time), at The New York Palace ... A live audio webcast of the presentation will be available ... www.arenapharm.com . A replay of the presentation will be available ...
(Date:11/24/2014)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... today that Sergio Traversa , chief executive officer, ... Event" Micro-Cap Growth Conference on Wednesday, December 3, 2014.  ... Bel Air Hotel, which is located at 11461 Sunset ... The presentation is scheduled for 8:30 a.m. ...
Breaking Medicine Technology:Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 4Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 5Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Relmada Therapeutics To Present At LD MICRO Conference 2
... , MISSISSAUGA, Ontario, Dec. 30 ... Holdings Inc. (OTC Bulletin Board: CGNH), a developer of ... IVD testing market, was interviewed in MedTech Executive. ... for developing its QL Care Analyzer device, the FDA ...
... , BOSTON, Dec. 30 Solos Endoscopy, ... looks forward to a prosperous 2010, following a solid year in ... , In the closing months of 2009, Solos Endoscopy, Inc. has ... MammoView(TM) line of surgical endoscopy instruments. This will allow the MammoView(TM) ...
Cached Medicine Technology:Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive 2Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive 3Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive 4Solos Endoscopy, Inc. Set to Increase Business Through Sales and Product Development in 2010 2
(Date:11/26/2014)... 26, 2014 The American Anthropological ... Association’s new director of meetings and conferences. Suvarnakar ... meeting, special events and conferences. , “I ... post,” said AAA Executive Director Ed Liebow. “She ... and energy. She was recognized in January as ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 For its ... independently published The AIS Report on Blue Cross and ... WellPoint, Inc. on the varied strategies the two Blues ... improve compliance with treatments for sleep apnea, ranging from ... disorder, because it’s linked to increased rates of a ...
(Date:11/26/2014)... GI for Life announced today, that they ... of their popular nutritional supplements: ColoVite Colon Health ... Discounts of 40% will be offered for a limited ... ColoVite supplement is a scientifically formulated vitamin supplement developed ... easy-to-take colon vitamin with ALL the nutrients associated with ...
(Date:11/26/2014)... Arlington, VA (PRWEB) November 26, 2014 ... foster greater effectiveness in containing and stopping Ebola, ... long-term stability in healthcare systems in West Africa. ... Care Systems to Stop Ebola: Anthropologists Offer Insights,” ... held by the American Anthropological Association (AAA), Fri., ...
(Date:11/26/2014)... Aurora, CO (PRWEB) November 26, 2014 For ... fast, the new LES MILLS BODYPUMP™ classes at ... be just the workout they've been looking for. The 45- ... with CU Anschutz Health and Wellness Center fitness club memberships. ... muscles. The workouts are fast-paced and are aimed at fast ...
Breaking Medicine News(10 mins):Health News:American Anthropological Association Appoints New Director of Meetings and Conferences: Ushma Suvarnakar 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 3Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2
... be genetic, researchers say , , MONDAY, Feb. 16 (HealthDay News) ... as likely to develop Parkinson,s disease, a new study finds. ... other studies have shown that people with Parkinson,s diseases are ... a family member with melanoma, they may be at risk ...
... who undergo surgery at teaching-intensive hospitals have better ... better survival rates apparently occur in white patients, ... advantage in surgical outcomes for patients in teaching-intensive ... expected from other studies," said study leader Jeffrey ...
... increase security inside and out, including children,s playgroundBROOKFIELD, ... provider of radio frequency identification monitoring systems and ... St. John,s Children,s Hospital of Springfield, Ill., to ... abduction. The recent installation of Safe Place(R) Infant/Child ...
... for nonsmokers, study finds , , MONDAY, Feb. 16 (HealthDay ... for stroke among women, with more consumption translating into ... finding stems from the tracking of both coffee habits ... women across nearly a quarter century. And it adds ...
... innovators recognized for technological breakthroughsCLEVELAND, Feb. 16 ... , is pleased to announce the winners of ... technological achievements of Northeast Ohio innovators who are ... and around the world. This year, a distinguished ...
... my 1HIE, LLC (My One ... e-Prescriptions have been sent from over 700 affiliated healthcare ... physicians to help them actively adopt the usage of ... Working with its member physicians organizations, my 1HIE ...
Cached Medicine News:Health News:Family History of Melanoma Doubles Parkinson's Risk 2Health News:White patients benefit more than blacks in surviving surgical complications at teaching hospitals 2Health News:White patients benefit more than blacks in surviving surgical complications at teaching hospitals 3Health News:RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at St. John's Children's Hospital 2Health News:RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at St. John's Children's Hospital 3Health News:Coffee Drinking Lowers Women's Stroke Risk 2Health News:Coffee Drinking Lowers Women's Stroke Risk 3Health News:Coffee Drinking Lowers Women's Stroke Risk 4Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 2Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 3Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 4Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 5Health News:my1HIE Reaches 1 Million e-Prescriptions 2
Micro-Kerrison Laminectomie Rongeur and Stella Punch, golden springs, with ejector. 18 cm - 7 1/8, very delicate, narrow footplate, small handle, 40 up-cutting, jaws 2 mm wide....
Kerrison (Micro) Laminectomy rongeur with ejector. 18 cm - 7 1/8, thick footplate, small handle, very delicate, 40 up-cutting, jaws 2 mm wide....
... The Tangent Posterior Impacted Instrument Set offers ... of the advantages offered by the Tangent ... preparation and the ability to reproduce the ... to ensure proper vertebral body distraction. A ...
... ValveTM, Hakim, H-V Lumbar Valve ... for meeting the complex demands ... response causes the valve to ... present, eliminating the need for ...
Medicine Products: